Biotech companies by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 24 biotech companies ranked by one-year price change, at +755%, ahead of Kodiak Sciences (+396%) and Twist Bioscience (+340%). Figures as of 18 Nov 2026, 19:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Moderna+755%
- Median
- +40.0%
- Combined market value
- SAR 3.14T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +755% | SAR 302.4B | SAR 747.44 | 3.64% down | 755% up | ||
| 2 | Kodiak SciencesKOD · Health Care | +396% | SAR 23.7B | SAR 362.01 | 0.30% down | 396% up | ||
| 3 | Twist BioscienceTWST · Health Care | +340% | SAR 30.1B | SAR 441.14 | 5.00% up | 340% up | ||
| 4 | ImmunityBioIBRX · Health Care | +193% | SAR 26.3B | SAR 24.77 | 5.48% up | 193% up | ||
| 5 | Revolution MedicinesRVMD · Health Care | +131% | SAR 130.1B | SAR 601.64 | 1.41% down | 131% up | ||
| 6 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | SAR 17.3B | SAR 107.02 | 0.14% up | 88% up | ||
| 7 | Kymera TherapeuticsKYMR · Health Care | +87.5% | SAR 39B | SAR 457.36 | 0.34% up | 87% up | ||
| 8 | CG OncologyCGON · Health Care | +85.3% | SAR 26.7B | SAR 298.39 | 0.77% up | 85% up | ||
| 9 | ExelixisEXEL · Health Care | +62.6% | SAR 63B | SAR 258.22 | 0.50% up | 63% up | ||
| 10 | BiogenBIIB · Health Care | +49.3% | SAR 139.2B | SAR 941.58 | 0.09% up | 49% up | ||
| 11 | Krystal BiotechKRYS · Health Care | +46.3% | SAR 34.9B | SAR 1,177.81 | 5.18% up | 46% up | ||
| 12 | ImmunovantIMVT · Health Care | +43.4% | SAR 25.9B | SAR 124.95 | 0.30% up | 43% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | +36.6% | SAR 41.1B | SAR 360.55 | 0.16% up | 37% up | ||
| 14 | AmgenAMGN · Health Care | +33.7% | SAR 902.4B | SAR 1,668.35 | 2.87% down | 34% up | ||
| 15 | Gilead SciencesGILD · Health Care | +32.9% | SAR 785.1B | SAR 632.94 | 0.89% down | 33% up | ||
| 16 | Bio-TechneTECH · Health Care | +25.6% | SAR 42.9B | SAR 273.02 | 0.21% up | 26% up | ||
| 17 | VaxcytePCVX · Health Care | +22.2% | SAR 34.7B | SAR 219.25 | 1.60% down | 22% up | ||
| 18 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | SAR 62.2B | SAR 614.19 | 1.31% down | 20% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | +13.6% | SAR 21.7B | SAR 177.97 | 5.25% up | 14% up | ||
| 20 | QiagenQGEN · Health Care | +12.0% | SAR 38.5B | SAR 186.29 | 0.17% down | 12% up | ||
| 21 | RepligenRGEN · Health Care | +4.58% | SAR 41.1B | SAR 643.65 | 5.81% up | 5% up | ||
| 22 | argenxARGX · Health Care | +3.60% | SAR 223.2B | SAR 3,549.91 | 0.12% down | 4% up | ||
| 23 | BioNTechBNTX · Health Care | -16.3% | SAR 77.9B | SAR 314.33 | 1.25% down | 16% down | ||
| 24 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | SAR 14.9B | SAR 154.09 | 2.32% up | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which biotech companies rank first by one-year price change?
Moderna (+755%), Kodiak Sciences (+396%) and Twist Bioscience (+340%) are the top three of the 24 biotech companies ranked by one-year price change as of 18 Nov 2026, 19:03 UTC.
How many biotech companies are in this ranking?
24 are ranked by one-year price change.
What are these biotech companies worth together?
The 24 biotech companies ranked by one-year price change have a combined market value of SAR 3.14T as of 18 Nov 2026, 19:03 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.